Prevalence and Predictive Factors of Neutropenia Among Patients With Breast Cancer Receiving Doxorubicincyclophosphamide Chemotherapy at a Cancer Center, Surin Hospital: A Retrospective Case-Control Study
Chalermchai Lertanansit,
Kaweewat Aekpongsan,
Panwassa Puapan
Abstract:Background: Despite significant advancements in breast cancer treatment with targeted therapy and immunotherapy, chemotherapy remains a crucial component across all stages. Anthracycline-based chemotherapy, while commonly administered, can lead to severe and potentially fatal complications such as febrile neutropenia.
Objectives: This study aimed to investigate the prevalence and predictive factors for developing neutropenia in patients with breast cancer undergoing an anthracycline-based chemotherapy regimen.… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.